FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048444834> ?p ?o ?g. }

• W3048444834 endingPage "2607" @default.
• W3048444834 startingPage "2607" @default.
• W3048444834 abstract "Introduction: Stress urinary incontinence (SUI) has an incidence of 15–80% in women. One of the most widely used surgical techniques for treatment is the placement of a suburethral transobturator tape (TOT). Although this technique has a relatively low morbidity rate, it is not exempt from intraoperative or postoperative complications, which can have an impact on functional recovery, understood as the return to routine life prior to the intervention. Aims: To assess the time for functional recovery in women operated on for SUI by TOT; to identify complications and related factors, according to anaesthetic risk, which condition the time to functional recovery; and proposals for improvements in the prevention of possible complications and in reducing functional recovery time. Materials and methods: A non-concurrent prospective observational multicenter study of 891 women undergoing TOT for stress urinary incontinence since 1 April 2003, who were successful in achieving urinary continence (completely dry). Study groups: GA (n = 443): patients with ASA I risk. GB (n = 306): patients with ASA II risk. GC (n = 142): patients with anaesthetic risk ASA III. Investigated variables: age, body mass index, follow-up time, secondary diagnoses, surgical history, obstetric-gynecological history, toxic habits, and complications derived from surgery: bleeding, pain, infection. Descriptive statistics, Student’s t test, Chi2, Fisher, ANOVA, multivariate analysis, significance for p < 0.05. Results: Mean age was 60.10 years (SD13.38), with no difference between groups. Mean body mass index (BMI) was 26.55 kg/m2 (SD 4.51), lowest in GA. GB had more HT (38.6%) than GC (23.23%), more type 2 diabetes (19.83% versus 10.56%), and more respiratory disorders (6.97% versus 2.11%). There were more women with anxiety in GB (19.3%) than in GC (6.33%) (p = 0.0221) and GA (10.51%) (p = 0.0004). There was more hypothyroidism in GB (16.08%) compared to GC (2.11%) and GA (9.07%). There was more history of curettage in GC (11.97%) versus GB (5.63%); and more pelvic surgery in GB (71.31%) and GC (66.9%) compared to GA (32.57%). There were more concomitant treatments with benzodiazepines in GC (27.46%) and GB (28.41%) than in GA (8.86%), and more parapharmacy treatments in GB (17.96%) than in GC (6.33%). Following the operation, 113 patients had some sign or symptom that required medical attention: in GA 48 (10.83%), in GB 49 (16.06%), in GC 16 (13.22%). Mean days until functional recovery in patients with complications: in GA 5.72 (SD2.05); bleeding 3 (SD1), pain 6.40 (SD1.34), and infection 7.33 (SD0.57), with fewer days for bleeding than for pain or infection. GB: 27.96 (SD 28.42), bleeding 3 (SD0), pain 46.69 (SD31.36), infection 10.83 (SD3.90); lowest for patients with bleeding. GC: 9.44 (SD 2.50); for bleeding 7.66 (SD2. 08), pain 10.66 (SD1.15), infection 10 (SD3.46); no differences. Overall, for women with bleeding, the time was 4.16 days (SD1.94); less in GA and GB than in GC. Pain, at 31.33 days (SD 30.70), was the factor that most delayed functional recovery; in GB women, it took longer to return to work due to pain (45.96, SD31.36) compared to GA (6.4, SD 1.34) and GC (10.66, SD1.15). In women with infection, overall mean time was 10.11 days (SD 3.61) with no difference between groups. Conclusions: Mean time for the return to normal activity in patients who underwent TOT for SUI is 5 days if there are no complications, and 16.91 days if there are any. The ASA-SP risk group classification can be used to anticipate functional outcomes. An ASA-PS risk-based functional recovery forecasting protocol should be adapted, especially ASA II patients who may present with long-term disabling postoperative pain. Preventive management measures are proposed that favour functional recovery." @default.
• W3048444834 created "2020-08-18" @default.
• W3048444834 creator A5005646784 @default.
• W3048444834 creator A5008458116 @default.
• W3048444834 creator A5011813020 @default.
• W3048444834 creator A5012559922 @default.
• W3048444834 creator A5025609612 @default.
• W3048444834 creator A5039233592 @default.
• W3048444834 creator A5042994037 @default.
• W3048444834 creator A5049489956 @default.
• W3048444834 creator A5049519923 @default.
• W3048444834 creator A5058492911 @default.
• W3048444834 creator A5068063330 @default.
• W3048444834 date "2020-08-11" @default.
• W3048444834 modified "2023-10-18" @default.
• W3048444834 title "The American Society of Anesthesiologists Physical Status (ASA-PS) Risk Group Classification Can Be Used to Anticipate Functional Recovery Outcomes after the Surgical Treatment of Female Urinary Incontinence with Transobturator Suburethral Tape" @default.
• W3048444834 cites W128546466 @default.
• W3048444834 cites W1974891305 @default.
• W3048444834 cites W1978283734 @default.
• W3048444834 cites W1978489076 @default.
• W3048444834 cites W1981272273 @default.
• W3048444834 cites W1988507070 @default.
• W3048444834 cites W2009458901 @default.
• W3048444834 cites W2010933276 @default.
• W3048444834 cites W2026102787 @default.
• W3048444834 cites W2048301249 @default.
• W3048444834 cites W2055899919 @default.
• W3048444834 cites W2065506323 @default.
• W3048444834 cites W2078239591 @default.
• W3048444834 cites W2098335710 @default.
• W3048444834 cites W2105980936 @default.
• W3048444834 cites W2123481698 @default.
• W3048444834 cites W2124039285 @default.
• W3048444834 cites W2147443002 @default.
• W3048444834 cites W2158623340 @default.
• W3048444834 cites W2185467805 @default.
• W3048444834 cites W2321194181 @default.
• W3048444834 cites W2326822896 @default.
• W3048444834 cites W2402794645 @default.
• W3048444834 cites W2463641722 @default.
• W3048444834 cites W2566030209 @default.
• W3048444834 cites W2587940458 @default.
• W3048444834 cites W2725888307 @default.
• W3048444834 cites W2783740767 @default.
• W3048444834 cites W2957955777 @default.
• W3048444834 cites W2964187914 @default.
• W3048444834 cites W2983294111 @default.
• W3048444834 cites W2994557709 @default.
• W3048444834 cites W4211036686 @default.
• W3048444834 doi "https://doi.org/10.3390/jcm9082607" @default.
• W3048444834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7464496" @default.
• W3048444834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32796713" @default.
• W3048444834 hasPublicationYear "2020" @default.
• W3048444834 type Work @default.
• W3048444834 sameAs 3048444834 @default.
• W3048444834 citedByCount "1" @default.
• W3048444834 countsByYear W30484448342022 @default.
• W3048444834 crossrefType "journal-article" @default.
• W3048444834 hasAuthorship W3048444834A5005646784 @default.
• W3048444834 hasAuthorship W3048444834A5008458116 @default.
• W3048444834 hasAuthorship W3048444834A5011813020 @default.
• W3048444834 hasAuthorship W3048444834A5012559922 @default.
• W3048444834 hasAuthorship W3048444834A5025609612 @default.
• W3048444834 hasAuthorship W3048444834A5039233592 @default.
• W3048444834 hasAuthorship W3048444834A5042994037 @default.
• W3048444834 hasAuthorship W3048444834A5049489956 @default.
• W3048444834 hasAuthorship W3048444834A5049519923 @default.
• W3048444834 hasAuthorship W3048444834A5058492911 @default.
• W3048444834 hasAuthorship W3048444834A5068063330 @default.
• W3048444834 hasBestOaLocation W30484448341 @default.
• W3048444834 hasConcept C120665830 @default.
• W3048444834 hasConcept C121332964 @default.
• W3048444834 hasConcept C126322002 @default.
• W3048444834 hasConcept C141071460 @default.
• W3048444834 hasConcept C188816634 @default.
• W3048444834 hasConcept C191093355 @default.
• W3048444834 hasConcept C23131810 @default.
• W3048444834 hasConcept C2778531004 @default.
• W3048444834 hasConcept C2780221984 @default.
• W3048444834 hasConcept C2993314993 @default.
• W3048444834 hasConcept C38180746 @default.
• W3048444834 hasConcept C61511704 @default.
• W3048444834 hasConcept C71924100 @default.
• W3048444834 hasConcept C77411442 @default.
• W3048444834 hasConceptScore W3048444834C120665830 @default.
• W3048444834 hasConceptScore W3048444834C121332964 @default.
• W3048444834 hasConceptScore W3048444834C126322002 @default.
• W3048444834 hasConceptScore W3048444834C141071460 @default.
• W3048444834 hasConceptScore W3048444834C188816634 @default.
• W3048444834 hasConceptScore W3048444834C191093355 @default.
• W3048444834 hasConceptScore W3048444834C23131810 @default.
• W3048444834 hasConceptScore W3048444834C2778531004 @default.
• W3048444834 hasConceptScore W3048444834C2780221984 @default.
• W3048444834 hasConceptScore W3048444834C2993314993 @default.
• W3048444834 hasConceptScore W3048444834C38180746 @default.
• W3048444834 hasConceptScore W3048444834C61511704 @default.
• W3048444834 hasConceptScore W3048444834C71924100 @default.
• W3048444834 hasConceptScore W3048444834C77411442 @default.

• next